Big Pharma lies about R&D costs to justify illicit profits

Thursday, March 10, 2011 by: Ethan A. Huff, staff writer
Tags: Big Pharma, drug development costs, health news

eTrust Pro Certified

Most Viewed Articles
Popular on Facebook
CDC issues flu vaccine apology: this year's vaccine doesn't work!
The five biggest lies about Ebola being pushed by government and mass media
Ultraviolet light robot kills Ebola in two minutes; why doesn't every hospital have one of these?
Tetanus vaccines found spiked with sterilization chemical to carry out race-based genocide against Africans
Biologist explains how marijuana causes tumor cells to commit suicide
Companies begin planting microchips under employees' skin
The best way to help your body protect itself against Ebola (or any virus or bacteria)
NJ cops bust teenagers shoveling snow without a permit
Russia throws down the gauntlet: energy supply to Europe cut off; petrodollar abandoned as currency war escalates
McDonald's in global profit free fall as people everywhere increasingly reject chemically-altered toxic fast food
W.H.O. contradicts CDC, admits Ebola can spread via coughing, sneezing and by touching contaminated surfaces
Top ten things you need to do NOW to protect yourself from an uncontrolled Ebola outbreak
Chemotherapy kills cancer patients faster than no treatment at all
FDA targets Dr. Bronner's Magic Soaps for sharing health benefits of coconut oil
U2's Bono partners with Monsanto to destroy African agriculture with GMOs
Why flu shots are the greatest medical fraud in history
Governments seize colloidal silver being used to treat Ebola patients, says advocate
Flu vaccine kills 13 in Italy; death toll rises

(NaturalNews) If you listen purely to the industry side of the story, you might think that drug companies are more than vindicated in selling brand-name drugs for sometimes thousands of times more than they cost to produce, and raking in billions of dollars in profits every year. After all, much of that profit covers research and development (R&D) costs, right? Wrong. According to a new study by Prof. Donald W. Light from the University of Medicine and Dentistry of New Jersey, and Rebecca Warburton from the School of Public Administration at the University of Victoria (http://www.pharmamyths.net/files/Biosocietie...), the average R&D costs to bring a new drug to market are a mere four percent of what Big Pharma claims they are -- and that is a generous estimate.

Drug companies constantly whine in their defense that the cost of producing a new drug tops $1 billion. They derive this lofty figure from a 2003 study by Joseph DiMasi from Tufts University, Ronald W. Hansen from the University of Rochester, and Henry Grabowski from Duke University (http://fds.duke.edu/db?attachment-25--1301-v...). The study, which was published in the Journal of Health Economics, was conducted out of the Tufts Center for the Study of Drug Development (TCSDD), a drug industry-funded group that "advocate[s] on behalf of initiatives and issues that further the cause of pharmaceutical innovation" (http://csdd.tufts.edu/about/corporate_sponso...).

Let's face it. Any study out of TCSDD is about as unbiased and credible as a court decision reached with the defendant sitting on the jury. The TCSDD study used by the drug industry to defend its billion-dollar drug production claims is based on an arbitrary sampling of drugs produced by ten pharmaceutical companies. These drugs are confidential, of course, and the 12 other firms that were invited to participate in the survey did not participate, according to reports.

So TCSDD basically produced a drug industry-funded study that contains drug industry-favored results. It includes a small and random sampling of unnamed drugs, and claims that such drugs cost an average of $802 million a piece to produce in 2000, or $1 billion in 2011 dollars when accounting for inflation. But the precise numbers and details are all but missing from the report. So how anyone in the scientific or regulatory community can willfully accept the report as anything other than hearsay is anyone's guess.

According to a recent piece in Slate, the Pharmaceutical Manufacturers Association (PhRMA), a pharmaceutical and biotechnology industry trade group, says that average drug development costs are even higher, having allegedly topped $1.32 billion in 2006. Based on this number, PhRMA is claiming that such costs increased by a whopping 64 percent in just six years, which is more than double the normal medical inflation rate.

The Light and Warburton study, which has been published in the journal BioSocieties, says that these figures are greatly overblown, and are simply not based in reality. The Slate piece cites additional research noting that 84 percent of the costs associated with the first research phase of drug development is covered by taxpayers via government grants. Add to this the report's estimate that the drug industry uses a little more than one percent of its sales revenue on basic research, and the costs in this department are very minimal.

Another little-known fact is that drug company R&D costs are tax exempt. They do not depreciate like normal investments do, either. When accounting for the many other tax breaks that drug companies receive, their actual net costs are cut by at least half of what they claim, according to the report. And when adjusting for "cost of capital," that amount should be cut in half again if it is to even approach an accurate estimate for R&D costs. After all, if drug companies are not willing to take a risk in the R&D department -- which is part of what running a business is all about -- then they should not be in business at all, right?

Apparently drug companies feel as though they are entitled to massive profits, even if they fail to produce a valuable product. No other industry receives the benefits that Big Pharma does in the name of public health, and yet the industry is constantly whining and threatening that unless it can keep riding the gravy train and receiving special treatment, the production of drugs will cease. This, of course, takes place as the industry marks up its drugs as much as 569,000 percent over cost, bilking insurance companies and the government out of billions (http://www.naturalnews.com/021831_FDA_reform...).

Sources for this story include:


Join over four million monthly readers. Your privacy is protected. Unsubscribe at any time.
comments powered by Disqus
Take Action: Support NaturalNews.com by linking back to this article from your website

Permalink to this article:

Embed article link: (copy HTML code below):

Reprinting this article:
Non-commercial use OK, cite NaturalNews.com with clickable link.

Follow Natural News on Facebook, Twitter, Google Plus, and Pinterest

Colloidal Silver

Advertise with NaturalNews...

Support NaturalNews Sponsors:

Advertise with NaturalNews...


Sign up for the FREE Natural News Email Newsletter

Receive breaking news on GMOs, vaccines, fluoride, radiation protection, natural cures, food safety alerts and interviews with the world's top experts on natural health and more.

Join over 7 million monthly readers of NaturalNews.com, the internet's No. 1 natural health news site. (Source: Alexa.com)

Your email address *

Please enter the code you see above*

No Thanks

Already have it and love it!

Natural News supports and helps fund these organizations:

* Required. Once you click submit, we will send you an email asking you to confirm your free registration. Your privacy is assured and your information is kept confidential. You may unsubscribe at anytime.